Growth Metrics

Bionano Genomics (BNGO) Depreciation & Amortization - Total (2025 - 2026)

Bionano Genomics recorded quarterly Depreciation & Amortization - Total of $700000.0 in Q1 2026, little changed quarter-over-quarter from $700000.0 in Q1 2025, and little changed year-over-year from $700000.0 in Q1 2025.

Bionano Genomics' Depreciation & Amortization - Total history runs 2 years deep, the most recent figure standing at $700000.0 for Q1 2026.

  • In Q1 2026, Depreciation & Amortization - Total changed 0.0% year-over-year to $700000.0; the TTM figure through Mar 2026 stood at $700000.0 (changed 0.0% YoY), while the FY2025 annual figure was $2.6 million, down 7.14% from the prior year.
  • Depreciation & Amortization - Total came in at $700000.0 for Q1 2026 at Bionano Genomics, roughly flat from $700000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $700000.0 in Q1 2025 to a low of $700000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 64.31 Mn
10 Bionano Genomics 14.92 Mn 539,417.67 3.25 Mn 700,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 700,000.00
Mar 31, 2025 700,000.00